# Study to Compare the Efficacy and Safety of Two Non-Preserved Artificial Tears for the Treatment of Dry Eye Signs and Symptoms

> **NCT00938704** · PHASE4 · COMPLETED · sponsor: **Allergan** · enrollment: 71 (actual)

## Conditions studied

- Dry Eye Syndromes

## Interventions

- **DRUG:** carboxymethylcellulose 0.5% +glycerin 0.9%
- **DRUG:** sodium hyaluronate 0.18%

## Key facts

- **NCT ID:** NCT00938704
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2011-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00938704

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00938704, "Study to Compare the Efficacy and Safety of Two Non-Preserved Artificial Tears for the Treatment of Dry Eye Signs and Symptoms". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00938704. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*